Brainzyme Google Ads — v3.1b4 Audit Dashboard

Current ROAS

1.36x

Target: 3.5x | May be inaccurate (29 conv. actions)

Current CPA

GBP 31

Target: GBP 20

Hard savings achieved

GBP 5.3k

Per month, already executed

Total improvement est.

GBP 24.6k

Hard saves + projected + TOFU/expansion

Consolidated issue list from v3.0 live-data audit and v3.1 skill-informed audit. 9 additional issues brought forward from v3.0 that were not in v3.1.

Critical -- Fix immediately

Conversion double-counting (29 actions) Critical

29 enabled conversion actions. No clarity on Primary vs Secondary. "Google Shopping App Purchase" catch-all likely double-counting with market-specific actions. Reduce to Purchase-only as Primary. Monitor 7 days post-change.

YouTube follow-on views as conversions Critical

YouTube video views counted as conversions. Now moved to Secondary (Session 2) but should be disabled entirely. Distorts Smart Bidding across all campaigns.

SERP USA Brand -- broken tracking Critical

0 conversions at 88% impression share. US checkout tag likely not firing. Test with Tag Assistant on US VPN. Check attribution window on US Purchase action.

Consent Mode v2 missing (DE + FR) Critical / Legal

Mandatory for EU/EEA since July 2025. Not mentioned in any of 55 files. Without it: 90-95% conversion metric drops in DE/FR AND potential GDPR enforcement. (v3.1 skill finding)

FR Ritaline in paid ads Critical / Legal

UFC-Que Choisir directly named Brainzyme. HAS Sept 2024 excludes supplements from ADHD treatment. Files 09-FR and 13-FR contradict. Remove AG3 from FR PMax and hold Campaign 6 from Search RSA. (v3.1 compliance finding)

High -- Fix this week

PMax UK 24-month stale creative High

2 asset groups from Jan/Apr 2024. ROAS collapsed 3.53x to 1.46x. Full creative refresh: new headlines, descriptions, 15+ images per asset group. Stale "New Year Sale" creative still running in March.

SERP UK ADHD structurally broken High

16/19 keywords at QS 0-3. 14.7% IS (85% lost to rank). New ad group has keywords but no RSA ads. GBP 832/mo at 0.97x ROAS.

PMax DE Ritalin stuck at GBP 0.01/day High

Historically best campaign (2.43x ROAS lifetime, 2,468 conversions). Enabled but zero impressions. Blocked on product feed. Potential: +GBP 2,700/mo.

RecoverUp conversion pollution High

Conversion actions from separate brand (RecoverUp) exist in the Brainzyme account. Remove or disable all RecoverUp-branded conversion actions. (v3.0 finding -- not in v3.1)

Ad extensions completely absent High

No sitelinks, callouts, structured snippets, or image extensions across all 55 files. Per benchmarks: high QS = 50% CPC discount, low QS = 400% premium. (v3.1 skill finding)

DE "Ohne Nebenwirkungen" -- HWG violation High

"Without side effects" is a medical claim. Replace with "Pflanzlich & Gut Vertraglich". (v3.1 compliance finding)

Bidding strategy mismatch High

All PMax campaigns have <50 conv/month but use Maximize Conversion Value. Per decision tree: <30 conv/month should be Maximize Clicks. (v3.1 skill finding)

PMax brand cannibalisation High

No brand exclusions in PMax when brand Search campaigns exist. PMax likely cannibalising brand Search traffic. (v3.1 skill finding)

Medium -- Optimise this month

CTV/Connected TV waste Medium

CTV placements in PMax likely consuming budget with minimal conversion attribution. Review placement reports, exclude if CPA significantly above average. (v3.0 finding -- not in v3.1)

SERP DE Brand -- 52% impression share Medium

Losing ~48% of brand IS in Germany at 10.9x ROAS. CPC ceiling raised to GBP 2.00 (done) but still under-serving.

80+ paused campaigns -- account bloat Medium

Navigation difficulty, risk of accidental re-enablement. Archive campaigns paused 90+ days with zero conversions. (v3.0 finding -- not in v3.1)

No ad schedule adjustments Medium

Bidding equally across all hours. Pull 90-day hourly conversion data. Suppress bids during 1am-6am. Expected: 5-10% CPA improvement. (v3.0 finding -- not in v3.1)

No device bid adjustments Medium

Mobile vs desktop CPA likely differs significantly. Pull device report, apply adjustments based on CPA variance. Expected: 5-15% CPA improvement. (v3.0 finding -- not in v3.1)

UK "#1 Rated" superlative Medium

Needs ASA-compliant substantiation documentation. If 4.74/5 is genuinely highest in category, document evidence.

Healthcare remarketing risk Medium

Google prohibits remarketing for health services. PMax campaigns may be doing this via audience signals. Verify PMax audience configuration. (v3.1 compliance finding)

MER not calculated Medium

Blended Marketing Efficiency Ratio (Total Revenue / Total Marketing Spend) is the true north metric. Not calculated anywhere in 55 files. (v3.1 skill finding)

Low -- Best practices

Inconsistent naming conventions Low

Mix of "PMax UK", "SERP UK Brand", "DG-COM ADHD". Adopt: [Type]-[Market]-[Theme] format. (v3.0 finding -- not in v3.1)

No shared negative keyword lists Low

Negatives managed per-campaign. Create shared lists: Brand, Medication, Competitor, Irrelevant terms. Apply to all relevant campaigns. (v3.0 finding -- not in v3.1)

FR Brand ad strength weak Low

Ads flagged "Average" or below. Add more headline/description variations to improve Quality Score. (v3.0 finding -- not in v3.1)

No audience signals on Search Low

Missing in-market/remarketing audiences on Search campaigns. Add as observation-only, review after 30 days. (v3.0 finding -- not in v3.1)

Summary: 5 Critical, 8 High, 8 Medium, 4 Low = 25 total issues. 9 items brought forward from v3.0 (marked with italics). All items have feedback controls below for your decisions.

Score revised from D (50/100) to F (38/100) after loading ads-google, ads-budget, ads-creative, ads-landing, paid-ads skills plus compliance, google-audit, and benchmarks references. Key additions: Consent Mode v2 gap, missing ad extensions, bidding mismatch, brand exclusion absence.

Category Scores (74-check framework)

Conversion Tracking (25% weight)25/100 -- CRITICAL

Wasted Spend (20% weight)55/100

Account Structure (15% weight)45/100

Keywords & Quality Score (15% weight)30/100 -- FAIL

Ads & Assets (15% weight)35/100 -- FAIL

Settings & Targeting (10% weight)40/100

Budget & Bidding Score

Allocation Strategy60/100

Bidding Strategies40/100

Scaling Readiness45/100

Budget Sufficiency65/100

Detailed Checks -- Conversion Tracking

X
G42: 29 enabled conversion actions. No clarity on Primary vs Secondary.
?
G43: Enhanced conversions status unknown -- not verified in any document.
X
G44: No server-side tracking mentioned anywhere across 55 files.
X
G45: Consent Mode v2 likely missing. Mandatory for EU/EEA since July 2025. Without it: 90-95% metric drops in DE/FR.
X
G47: YouTube follow-on views were Primary (now fixed). 28 other actions unaudited.
X
G-CT1: Likely double-counting across 29 actions. Explicitly flagged in strategy docs.
?
G-CT3: SERP USA Brand: 0 conversions at 88% impression share. Likely broken tag on US store.

Detailed Checks -- Ads & Assets

X
G26: New Focus & Attention ad group has no RSA ad. Keywords without ads don't serve.
X
G31: PMax assets 24 months old. Should refresh every 8-12 weeks (8x overdue).
?
G32: No mention of video assets in PMax anywhere.
X
G-AD1: Stale "New Year Sale" creative still running in late March.
X
G50-53: No sitelinks, callouts, structured snippets, or image extensions mentioned in any file. High severity gap.

Detailed Checks -- Keywords & QS

X
G20: SERP UK ADHD: 16/19 keywords at QS 0-3. Account-wide QS likely <5.
X
G21: >25% of keywords with QS <=3. Critical threshold breached.
X
G22: SERP UK ADHD at 14.7% impression share. 85% lost to rank.
!
G24: US pages all have same H1, no reviews. DE/FR landing pages need live verification.

What the skills caught that previous reviews missed

Gap	Source Skill	Why It Matters
Consent Mode v2	compliance.md	Mandatory for EU/EEA since July 2025. Not in any of 55 files.
Ad extensions absent	google-audit G50-53	High QS = 50% CPC discount. Low QS = 400% premium.
Bidding mismatch	ads-budget decision tree	<30 conv/month should be Max Clicks, not MaxConvValue.
Brand exclusions in PMax	google-audit G07, G-PM3	PMax without exclusions cannibalises brand Search.
Healthcare remarketing	compliance.md	Google prohibits remarketing for health services.
MER not calculated	ads-budget	Blended Marketing Efficiency Ratio is the true north metric.

Multiple compliance issues found across 4 markets. Some are legal requirements (Consent Mode v2), others are regulatory risks (DGCCRF, HWG, ASA, FTC).

Critical (fix immediately)

FR Ritaline in paid ads CRITICAL

UFC-Que Choisir directly named Brainzyme in "Attention aux pilules anti-TDAH". HAS Sept 2024 excludes supplements from ADHD treatment. Files contradict: 09-FR says NEVER, but 13-FR includes Ritaline Alternative PMax asset group (AG3) and 14 includes Search RSA Campaign 6. Remove both. Keep organic/SEO only.

Consent Mode v2 (DE + FR) CRITICAL / LEGAL

Mandatory for EU/EEA since July 2025. Not mentioned in any of 55 files. Without it: 90-95% conversion metric drops AND potential GDPR enforcement. Verify implementation on brainzyme.de and brainzyme.fr immediately.

High severity

DE "Ohne Nebenwirkungen" HIGH / HWG

"Without side effects" is a medical claim that violates Heilmittelwerbegesetz (HWG). Found in DE PMax AG2 headlines. Replace with "Pflanzlich & Gut Vertraglich" (Plant-Based & Well-Tolerated).

FR "Traitement Naturel Fatigue" HIGH / DGCCRF

"Traitement" = "treatment" in French. DGCCRF may consider this a medical claim for a supplement. Change to "solution naturelle" or "soutien naturel".

US Elite pricing error HIGH / MISLEADING

Price Extensions in 13-US list Focus Elite at "$29" when it's GBP 47 (~$60+). This would be misleading advertising under FTC guidelines. Fix before deploying.

Medium severity (monitor)

UK "#1 Rated" superlative MEDIUM / ASA

Needs ASA-compliant substantiation. If 4.74/5 is genuinely highest in category, document evidence. Otherwise soften to "One of the UK's Highest-Rated".

DE ADHS in ad copy MEDIUM / HWG

Strategy bans "ADHD" (English) and "TDAH" (French) but uses "ADHS" (German) freely in headlines. Legal under current HWG interpretation but BfArM has been tightening supplement rules. Monitor.

Healthcare remarketing risk UNKNOWN

Google prohibits remarketing for health services. PMax campaigns may be doing this via audience signals. Verify PMax audience configuration.

Compliance pass (good)

P
No "ADHD" in any English ad copy (ASA compliant)
P
No "nootropic" in any customer-facing copy
P
No "neurodivergent" combined with functional cognitive claims
P
No treatment/cure/prevent claims in UK or US copy
P
All claims use "supports", "helps", "contributes to"
P
US uses structure/function claims only (FTC compliant)

These decisions are strategically sound and data-supported. Continue executing.

Demand Gen pause DONE Saves GBP 3,476/mo

7 campaigns at 0.21x ROAS. Pure waste. No argument.

US reduction DONE Saves GBP 1,636/mo

PMax US Adderall paused (0.01x ROAS, GBP 6,444 CPA). PMax USA halved to GBP 30/day. 40+ historical non-brand US campaigns have never sustained >2x ROAS.

DE market -- proceed aggressively BEST OPPORTUNITY

Brainzyme is the ONLY brand running Google Ads on focus/nootropic keywords in Germany. BRAINEFFECT pivoted to gut health. Zero competition window. Ritalin/ADHS Search + Konzentration campaigns should be top priority.

FR anti-fatigue mentale pivot WHITE SPACE

52% of French adults report fatigue as #1 complaint. "Anti fatigue mentale" has 500-1,500 monthly searches with near-zero PPC competition. Safer than Ritaline positioning and higher upside.

UK problem-aware keyword strategy SMART

Targeting "brain fog help", "can't concentrate" at GBP 0.50-1.50 CPC instead of GBP 3-4 for generic supplement terms. 7 well-segmented ad groups.

SERP DE brand CPC increase DONE

Raised from GBP 1.00 to GBP 2.00. At 10.9x ROAS and only 52% impression share, was leaving profitable impressions on the table.

Negative keywords on SERP UK ADHD DONE

13 phrase-match negatives for medication/prescription terms. Good call excluding kids/children since FOCUS ORIGINAL works for ages 10-15.

70/20/10 budget framework SOUND

UK 45% / DE 41% / FR 14% / US 2%. Follows proven/scaling/testing logic.

These items should be rolled back or not proceeded with. Each has a clear reason.

ROAS guardrails ALREADY ROLLED BACK

200% Target ROAS on campaigns with 24-month-old creative forced Smart Bidding into a death spiral. PMax FR dropped from 1.49x to 0.86x within days. Correct sequence: creative refresh FIRST, then guardrails. The rollback was the right call.

FR Ritaline paid ads DO NOT PROCEED

Files 09-FR and 13-FR directly contradict each other. UFC-Que Choisir named Brainzyme. HAS Sept 2024 guidelines exclude supplements from ADHD treatment. Remove AG3 from FR PMax plan. Hold Campaign 6 from Search RSA plan. Keep organic/SEO presence only.

DE "Ohne Nebenwirkungen" headline REMOVE

HWG violation. "Without side effects" is a medical claim. Replace with "Pflanzlich & Gut Vertraglich" (Plant-Based & Well-Tolerated).

US Elite pricing in ad copy FIX

Price Extensions list Focus Elite at "$29" when it's GBP 47 (~$60+). Misleading advertising under FTC guidelines.

Creative brief Image 8 "beaker" REVISE

File 10 specifies "beaker, clinical aesthetic" but brand exclusion rules explicitly ban beakers. Replace with peer-reviewed journal or ingredient close-up on marble.

These are hard blockers that must be resolved before new campaigns launch or creative deploys.

Hard Blockers

Audit all 29 conversion actions HARD BLOCKER

Reduce to Purchase-only as Primary. With 29 polluted actions, every Smart Bidding decision is compromised. The ROAS figures themselves may not be accurate. Nothing else should proceed until this is done.

Verify Consent Mode v2 (DE + FR) LEGAL REQUIREMENT

Mandatory for EU/EEA since July 2025. If not implemented: 90-95% of conversion data from EU traffic is lost AND potential GDPR enforcement risk.

Live-verify all 64 landing page URLs 5-MINUTE FIX

File 11 URLs from Google Docs extraction, not live crawling. File 05-UK found 6/9 guessed URLs returning 404. Batch crawl before any campaign goes live.

Quick Wins (unblock immediately)

Connect DE product feed USER ACTION

Two proven campaigns (2.43x and 2.04x ROAS) sitting at GBP 0.01/day because product feed isn't connected. Easiest revenue recovery in the account.

Add RSA to Focus & Attention ad group COPY READY

Ad group created with 10 keywords but no RSA ad. Keywords without ads don't serve. Copy exists in file 04.

Add ad extensions to ALL Search campaigns NEW FINDING

Sitelinks, callouts, structured snippets, image extensions -- entirely missing from all 55 files. Per benchmarks: high QS from extensions = 50% CPC discount. Low QS = 400% premium.

Remove compliance violations from ad copy BEFORE DEPLOY

"Ohne Nebenwirkungen" (DE), "Traitement" (FR), US Elite pricing ($29). All must be fixed before any new copy goes live.

Campaign creation note

API campaign creation is broken WORKAROUND

create_campaign MCP tool failed 5 different ways (documented as T5). All 5 new Search campaigns must be created manually in Google Ads UI. Deployment specs in file 05 are UI-ready with every setting specified.

30-day focus: Fix all critical and high-priority issues. These are the foundation -- nothing else matters until tracking is accurate and creative is refreshed.

Week 1 -- Conversion tracking & compliance

C1: Fix conversion double-counting Critical

Audit all 29 conversion actions. Reduce to Purchase-only as Primary. Change "Google Shopping App Purchase" catch-all to Secondary. Monitor 7 days post-change.

C2: Disable YouTube follow-on views Critical

Remove entirely as conversion action. Not just secondary -- disable. Distorts Smart Bidding across all campaigns.

C3: Investigate USA Brand tracking Critical

Test US checkout tag with Tag Assistant + VPN. 0 conversions at 88% IS. Fix or pause campaign.

C4: Verify Consent Mode v2 (DE + FR) Critical / Legal

Mandatory for EU/EEA since July 2025. Check implementations on brainzyme.de and brainzyme.fr. Without it: 90-95% metric drops.

C5: Remove FR Ritaline from paid ads Critical / Legal

Remove AG3 from FR PMax plan. Hold Campaign 6 from Search RSA. UFC-Que Choisir named Brainzyme. Keep organic/SEO only.

H4: Remove RecoverUp conversion actions High

Disable all RecoverUp-branded conversion actions in the Brainzyme account. Cross-brand pollution.

H6: Remove "Ohne Nebenwirkungen" from DE copy High

HWG violation. Replace with "Pflanzlich & Gut Vertraglich". Also fix FR "Traitement" and US Elite pricing.

Week 1 -- Quick wins (same week)

Live-verify all 64 landing page URLs 5 min

Batch crawl. Previous round found 6/9 guessed URLs returning 404. Prevents paid traffic to dead pages.

H5: Add ad extensions to ALL Search campaigns High

Sitelinks (4+), callouts (4+), structured snippets, image extensions. Entirely missing. Direct QS and Ad Rank impact. Free money.

H2: Add RSA to Focus & Attention ad group High

Keywords exist but no ads serve. Copy written in file 04.

Week 2 -- Revenue recovery

H3: Connect DE product feed High

Unblocks PMax DE Ritalin (2.43x ROAS) + PMax DE Austria. Easiest revenue recovery in the account. Potential: +GBP 2,700/mo.

H8: Add brand exclusions to PMax High

Prevent PMax from cannibalising brand Search campaigns. Check and configure via Google Ads UI.

Week 3-4 -- Creative refresh

H1: PMax UK creative refresh High

Generate new headlines (15), descriptions (5), images (15+). Replace all 24-month-old assets. Remove "New Year Sale" seasonal copy. Use SCENE framework.

Review conversion data quality Verify

Compare pre/post conversion volumes. Confirm double-counting eliminated. Verify Smart Bidding has stabilised on new data.

Week 4 -- Verify and stabilise

Monitor creative refresh performance

Check PMax UK asset ratings (Best/Good/Low). Allow 14 days learning period. Do NOT add guardrails yet.

60-day focus: Medium-priority optimisations. Only begin after 30-day tracking fixes are verified and creative refresh has exited learning phase.

Optimisations

M1: Review CTV placements Medium

Pull PMax placement reports. Identify Connected TV spend and conversion rate. Exclude if CPA is 2x+ above campaign average.

M2: Fix SERP DE Brand impression share Medium

Currently ~52% IS at 10.9x ROAS. CPC ceiling already raised to GBP 2.00. Run auction insights, increase budget further if rank-limited.

M3: Archive paused campaigns Medium

Remove 80+ campaigns paused 90+ days with zero conversions. Clean up account structure.

M4: Add ad schedule adjustments Medium

Pull hourly data. Suppress bids during 1am-6am if conversion rate is significantly below average. Expected: 5-10% CPA improvement.

M5: Add device bid adjustments Medium

Pull device performance. Apply adjustments based on CPA variance. Expected: 5-15% CPA improvement.

M8: Calculate MER Medium

Establish blended Marketing Efficiency Ratio as the true north metric. Total Revenue / Total Marketing Spend across all channels.

Creative expansion

PMax DE creative refresh (German) High

Apply same creative refresh process to PMax DE. All copy in German. Use Phase 3 German ad copy from strategy dashboard.

PMax FR creative refresh (French) High

Refresh PMax FR with French-language creative. Target "anti-fatigue mentale" angle -- completely unowned keyword cluster.

Deploy new campaigns (Python scripts)

6 Search campaigns deployed PAUSED DONE

UK Problem-Aware, UK Dopamine & Smart Focus, DE Ritalin ADHS, DE Konzentration, FR Anti-Fatigue Mentale, FR TDAH & Ritaline. All deployed via Python scripts.

US Brain Fog Search — ready to deploy READY

Campaign spec complete. Deploy when ready to activate US market expansion.

7 remaining Search campaigns — blocked by landing pages BLOCKED

PREC, GUIDE, COMP, QUIZ landing page types needed. Build static HTML/JS pages before deploying remaining campaigns.

90-day focus: Review all changes, implement best practices, launch new market campaigns, and apply guardrails only after creative performance is established.

Review and adjust

Full performance review

Compare 30-day pre vs post metrics. Validate ROAS and CPA improvements. Identify any campaigns still below target.

Apply ROAS guardrails (if ready)

Only if creative refresh has been live 30+ days and shows stable ROAS above 1.5x. Start with modest floors (150%) and increase gradually. Previous premature attempt caused PMax FR to drop from 1.49x to 0.86x.

Best practices

L1: Standardise naming conventions

Adopt [Type]-[Market]-[Theme] format across all campaigns.

L2: Create shared negative keyword lists

Brand, Medication, Competitor, Irrelevant -- apply to all relevant campaigns.

L3: Improve FR Brand ad strength

Add more headline/description variations to improve Quality Score.

L4: Add audience signals to Search

In-market health supplement audiences as observation-only. Review after 30 days.

New campaign launches

SERP FR Anti-Fatigue Mentale Search

French anti-fatigue mentale keywords -- completely uncontested cluster. 500-1,500 monthly searches. Zero PPC competition.

SERP DE Konzentration Search

German focus/concentration keywords. Brainzyme is currently the only bidder on these terms in DE.

Scale DE aggressively

Once Ritalin/ADHS Search + Konzentration campaigns are live and converting, increase DE budget allocation. Zero competition window won't last forever.

Budget Allocation

45%

GBP 9,180/mo | Proven

41%

GBP 8,364/mo | Scaling

14%

GBP 2,856/mo | Scaling

GBP 360/mo | Defence

UK -- Problem-Based Focus

"Can't concentrate? There's a plant-powered solution."

Strategy: Target problem-aware keywords at GBP 0.50-1.50 CPC (vs GBP 3-4 generics)
Campaigns: Brand Search (9.01x ROAS), Problem-Aware Search (new), PMax UK (refresh)
Trust signals: 6,020+ reviews, 2,000+ doctors, 365-day returns, Made in Scotland
Products to feature: Starter Bundle (£44), FOCUS PRO (£29), FOCUS ORIGINAL (£18)
Key keywords: brain fog help, can't concentrate, focus supplements, mental fatigue
Avoid: Generic "nootropics" messaging (MLP/NooCube own it). Brain Quiz does NOT convert for paid traffic.
SERP UK ADHD QS catastrophe (16/19 at QS 0-3). Creative direction: scientific/medical aspirational, NOT leafy/natural.

DE -- Ritalin Alternative + Konzentration (BIGGEST OPPORTUNITY)

"Konzentration naturlich steigern — pflanzlich, rezeptfrei, wirksam in 60 Minuten"

Strategy: Exploit zero-competition window. Only brand bidding in Germany.
Campaigns: Brand Search (10.9x ROAS), Ritalin/ADHS Search (new), Konzentration Search (new), PMax DE (refresh)
Trust signals: "Von über 2.000 medizinischen Fachkräften empfohlen", 365-Tage-Garantie
Unique: BRAINEFFECT pivoted to gut health. No German domestic brand bidding.
Products: Starter-Paket EUR 47,80, FOCUS PRO (competitive at EUR 31.75)
Blockers: Product feed not connected (blocks PMax DE Ritalin at 2.43x ROAS)
ALL creative MUST be in German. Site confirmed in German (31 Mar 2026).
Watch: ADHS in ad copy (HWG risk). "Ohne Nebenwirkungen" must be removed.

FR -- Anti-Fatigue Mentale (White Space)

"Anti-fatigue mentale — concentration naturelle, fabriqué en Écosse"

Strategy: Dual-track: shift from Ritaline (60% now → 20% by M6) to anti-fatigue mentale (40% → 80%)
Campaigns: Brand Search (16.5x ROAS), Anti-Fatigue Mentale Search (new), PMax FR (refresh)
Trust signals: "Recommandé par 2000+ professionnels de santé", garantie 365 jours
Opportunity: 52% of French adults report fatigue as #1 complaint. EUR 250m pharmacy market. Zero PPC competition.
Products: Pack Découverte EUR 47,80, FOCUS PRO EUR 31,75
Positioning: "Fabriqué en Écosse" = premium/exotic (Scotland has positive associations in France).
CRITICAL: Do NOT bid on TDAH keywords in Search. UFC-Que Choisir named Brainzyme. Fix "Traitement" language.

US -- Brand Defence Only (Survival Mode)

Minimal spend. Brand search only. No expansion.

Strategy: GBP 30/day brand search only. 40+ historical non-brand campaigns never sustained >2x ROAS.
Issues: All pages show same H1, zero reviews visible. SERP USA Brand has 0 conversions (likely broken tag).
Rule: Scale only if ROAS sustains >1.5x for 3+ months.
Fix US Elite pricing ($29 shown, actual ~$60). Verify conversion tag on US store checkout.

Ready-to-deploy ad copy from the master strategy. 15 headlines + 5 long headlines + 5 descriptions per market. All compliance-checked.

UK Headlines (15)

#	Headline (max 30 chars)	Angle
1	Focus Supplements From £18	Price entry
2	{KeyWord:Natural Focus Support}	DKI
3	Trusted by 2,000+ Doctors	Authority
4	4.74/5 From 6,020+ Reviews	Social proof
5	Plant-Powered Brain Support	Category
6	Made in Scotland. GMP Certified.	Trust
7	365-Day Money-Back Guarantee	Risk reversal
8	Try All 3 Formulas for £44	Bundle
9	Find Your Focus in 60 Minutes	Speed
10	The UK's Original Focus Supplement	Heritage
11	Subscribe & Save Up to 33%	Value
12	3 Formulas. Find Your Match.	Choice
13	Free UK Delivery on All Orders	Shipping
14	Vegan. Allergen-Free. Plant-Based.	Clean label
15	Science-Backed Brain Nutrition	Credibility

Long Headlines (5)

Plant-Powered Focus Supplements Trusted by 2,000+ Medical Professionals
From £18/Month — The UK's Most-Reviewed Focus Supplement (4.74/5)
Find Your Perfect Focus Formula — Take Our Free 2-Minute Brain Quiz
Made in Scotland. 6,020+ Verified Reviews. 365-Day Guarantee.
3 Focus Formulas From £18 — Mild, Strong, or Elite. Try the Starter Bundle.

Descriptions (5)

Plant-powered supplements for focus, memory & mental energy. Trusted by 2,000+ doctors worldwide. Made in Scotland. Try risk-free with 365-day returns.
Not sure which formula? Take our Brain Quiz and get a personalised recommendation. Starter Bundle: all 3 formulas for £44. Free UK delivery.
6,020+ verified reviews at 4.74/5. GMP & HACCP certified. Vegan, allergen-free. Subscribe and save up to 33% on every order.
Brainzyme FOCUS PRO for strong focus & motivation. FOCUS ELITE for stress-free focus & mood. FOCUS ORIGINAL for mild everyday calm. From £18/month.
The UK's first natural focus supplement brand since 2016. Plant-powered, science-backed, made in Edinburgh. Feel the difference in 60 minutes.

DE Headlines (15) — ALL IN GERMAN

#	Headline	Angle
1	Konzentration natürlich steigern	Category
2	{KeyWord:Natürliche Konzentration}	DKI
3	Von 2.000+ Ärzten empfohlen	Authority
4	365 Tage Geld-zurück-Garantie	Risk reversal
5	Pflanzliche Fokus-Kapseln	Category
6	4,74/5 aus 6.020+ Bewertungen	Social proof
7	Hergestellt in Schottland	Trust/origin
8	3 Formeln — Finden Sie Ihre	Choice
9	Starter-Paket nur EUR 47,80	Bundle
10	Wirksam in 60 Minuten	Speed
11	Vegan & Allergenfrei	Clean label
12	GMP & HACCP Zertifiziert	Quality
13	Bis zu 33% mit Abo sparen	Value
14	Konzentration ohne Koffein	Differentiator
15	Pflanzlich. Rezeptfrei. Wirksam.	Triple benefit

Long Headlines (5)

Pflanzliche Konzentrations-Kapseln — Von über 2.000 medizinischen Fachkräften empfohlen
Ab EUR 19,80/Monat — Deutschlands meistbewertetes Fokus-Supplement (4,74/5)
3 Formeln für jeden Bedarf — Mild, Stark oder Elite. Jetzt Starter-Paket testen.
365 Tage Geld-zurück-Garantie — Kein Risiko. Hergestellt in Schottland. GMP-zertifiziert.
Natürliche Konzentrationshilfe — Pflanzlich, rezeptfrei, wirksam in 60 Minuten.

Descriptions (5)

Pflanzliche Nahrungsergänzung für Konzentration, Gedächtnis & mentale Energie. Von über 2.000 Ärzten empfohlen. 365 Tage Geld-zurück-Garantie.
3 Formeln ab EUR 19,80/Monat. FOCUS ORIGINAL (mild), FOCUS PRO (stark), FOCUS ELITE (stressfrei). Starter-Paket: alle 3 für EUR 47,80.
6.020+ verifizierte Bewertungen mit 4,74/5. GMP & HACCP zertifiziert. Vegan, allergenfrei, hergestellt in Schottland.
Nicht sicher welche Formel? Machen Sie unser 2-Minuten Brain Quiz. Kostenlose Lieferung ab EUR 40. Bis zu 33% sparen mit Abo.
Seit 2016 Europas erstes natürliches Fokus-Supplement. Pflanzlich, wissenschaftlich belegt. Spüren Sie den Unterschied in 60 Minuten.

FR Headlines (15) — ALL IN FRENCH

#	Headline	Angle
1	Concentration naturelle	Category
2	{KeyWord:Focus Naturel}	DKI
3	Anti-fatigue mentale	White space
4	Recommandé par 2000+ médecins	Authority
5	Fabriqué en Écosse	Trust/origin
6	365 jours satisfait ou remboursé	Risk reversal
7	4,74/5 — 6020+ avis vérifiés	Social proof
8	Compléments végétaux	Clean label
9	3 formules — Trouvez la vôtre	Choice
10	Pack Découverte EUR 47,80	Bundle
11	Efficace en 60 minutes	Speed
12	Vegan & Sans allergènes	Clean label
13	GMP & HACCP Certifié	Quality
14	Économisez jusqu'à 33%	Value
15	Végétal. Sans ordonnance. Efficace.	Triple benefit

Long Headlines (5)

Compléments alimentaires pour la concentration — Recommandés par 2000+ professionnels de santé
À partir de EUR 19,80/mois — Le supplément focus le mieux noté d'Europe (4,74/5)
3 formules adaptées à vos besoins — Légère, forte ou élite. Testez le Pack Découverte.
Garantie 365 jours — Sans risque. Fabriqué en Écosse. Certifié GMP.
Anti-fatigue mentale naturel — Végétal, sans ordonnance, efficace en 60 minutes.

Descriptions (5)

Compléments végétaux pour la concentration, la mémoire et l'énergie mentale. Recommandés par 2000+ médecins. Fabriqué en Écosse. Garantie 365 jours.
3 formules à partir de EUR 19,80/mois. FOCUS ORIGINAL (léger), FOCUS PRO (fort), FOCUS ELITE (sans stress). Pack Découverte: les 3 pour EUR 47,80.
6020+ avis vérifiés à 4,74/5. Certifié GMP & HACCP. Vegan, sans allergènes, fabriqué en Écosse.
Pas sûr de votre formule? Faites notre Brain Quiz en 2 minutes. Livraison gratuite dès EUR 40. Économisez jusqu'à 33% avec l'abonnement.
Depuis 2016, le premier complément naturel pour la concentration en Europe. Végétal, scientifiquement prouvé. Ressentez la différence en 60 minutes.

Creative Image Brief (per market)

Type	Count	Model	Description
Product-in-scene	6	Flux Kontext Max	Morning desk, study session, kitchen counter, office, outdoor, evening wind-down
Lifestyle (no product)	5	Nano Banana Pro	Focused worker, student studying, morning routine, walking meeting, parent multitasking
Text-heavy/badges	4	Ideogram 3.0	Trust badge, review score, price entry, guarantee

Total per market: 15 images × 3 dimensions (1200x628, 1200x1200, 960x1200) × 2 variations = 90 images. 3 markets = 270 total. Est. cost: ~£36. 62 of 270 already generated.

Lead with these in every market. No single competitor matches all of these simultaneously. This is the moat.

Advantage	Brainzyme	Best Competitor	Gap
Verified reviews	6,020+ at 4.74/5	Mind Lab Pro: 2,523 at 4.4/5	2.4x more
Medical professional trust	2,000+ doctors	Zero competitors claim this	Unique
Money-back guarantee	365 days	Industry standard: 30-60 days	6-12x longer
Product range	3-formula tiered system	Every competitor sells one product	Unique
Price entry point	£18/month (ORIGINAL)	Mind Lab Pro: £55+, NooCube: £40+	3x cheaper
Try-all option	Starter Bundle: all 3 for £44	No competitor offers a try-all bundle	Unique
Manufacturing origin	Made in Scotland, GMP & HACCP	MLP, NooCube, Hunter Focus: all USA	UK provenance
Subscription savings	16-33% off	Most competitors: 10-15% or none	2x savings

How to use in ads

Every ad should reference at least 2 of these advantages. The combination of price (£18) + social proof (6,020 reviews) + authority (2,000 doctors) + risk reversal (365 days) is a messaging stack no competitor can counter. Use in headlines, descriptions, sitelinks, and callout extensions across all markets.

Per-market lead advantage

Price + Reviews

"From £18. 6,020+ reviews."

Zero competition

Only brand bidding. Own the space.

Doctor trust

"2000+ professionnels de santé"

Value vs giants

"$60 for 3 formulas vs $69-139 for one"

Hard savings (done)

GBP 5,298/mo

Already executed

Projected revenue gains

GBP 19,314/mo

Creative + DE + new campaigns + TOFU

Total monthly uplift

GBP 24,612/mo

Combined impact

Image gen costs incurred

GBP 5.22

62 images across 2 sessions

Action	Type	Status	Monthly Impact
Pause Demand Gen (7 campaigns)	Hard save	DONE	+GBP 3,414
PMax US Adderall pause + USA budget cut	Hard save	DONE	+GBP 1,636
ADHD negative keywords	Hard save	DONE	+GBP 248
Re-enable PMax DE Ritalin	Revenue est.	BLOCKED	+GBP 2,700
US budget reallocation to DE	Reallocation	PENDING	+GBP 1,900
PMax creative refresh (all markets)	Revenue est.	WEEK 3-4	+GBP 5,864
v3.1b4 — Expansion & TOFU Strategy
6 Search campaigns deployed PAUSED (of 14 total — 8 remaining, blocked by landing pages)	Revenue est.	PAUSED	+GBP 3,200
16 PMax campaigns (12 new + 4 legacy) — v4.0b intent-split architecture	Revenue est.	PAUSED	+GBP 2,800
13 new PMax asset groups fully deployed (assets, listing groups, search themes, audience signals)	Revenue est.	DONE	incl. above
TOFU lead magnets (Dopamine & GABA guides)	Revenue est.	PHASE 2	+GBP 1,750
Page speed: static HTML replacing PageFly	CVR uplift	PLANNED	+GBP 1,100
Total			+GBP 24,612/mo

Important caveat: Hard savings (GBP 5,298/mo) are real and already achieved. The remaining GBP 10,464/mo depends on creative refresh restoring historical ROAS levels and DE product feed being connected. Plausible but not guaranteed.

Image generation costs (already incurred)

Session	Images	Models	Cost
Session 1 (31 Mar)	20	Flux Kontext Max, Nano Banana Pro	~GBP 2.06
Session 2 (1 Apr)	42	Flux Kontext Max, Nano Banana Pro, Ideogram v3	~GBP 3.16
Total	62		~GBP 5.22

Interactive projections using google-ads-math formulas. Drag sliders to model different scenarios. All calculations use 30.4 days/month. Inputs are pre-filled with current account data.

Creative Refresh Impact Projector

Model what happens to revenue when PMax ROAS recovers after refreshing 24-month-old creative. Based on historical ROAS trajectory.

PMax UK ROAS target2.0x

PMax DE ROAS target2.0x

PMax FR ROAS target1.8x

UK weekly spendGBP 1,555

DE weekly spendGBP 2,712

FR weekly spendGBP 1,177

Current monthly revenue

GBP 32,140

Projected monthly revenue

GBP 45,390

Monthly revenue uplift

+GBP 13,250

Formula: Monthly Revenue = Weekly Spend x 4.34 x ROAS. Current ROAS: UK 1.44x, DE 1.36x, FR 1.49x. Historical peak: UK 3.53x (Jan 2025).

Impression Share Opportunity

What revenue is being left on the table from lost impression share?

DE Brand IS target80%

UK ADHD IS target50%

DE Brand CTR12.0%

DE Brand CVR6.0%

Avg order valueGBP 35

DE Brand: current 52.1% IS--

UK ADHD: current 14.7% IS--

Est. missed clicks/month (DE)--

Est. missed conversions/month (DE)--

Est. missed revenue/month (total)--

Formula: Missed Impr = Current Impr x ((1 - IS) / IS). Missed Clicks = Missed Impr x CTR. Missed Conv = Missed Clicks x CVR. Missed Rev = Missed Conv x AOV.

Break-Even ROAS Calculator

What ROAS do you need to break even given your margin?

Gross margin50%

Monthly ad spendGBP 20,000

Current blended ROAS2.1x

Break-even ROAS--

Current revenue/month--

Current gross profit/month--

Net profit after ad spend--

Verdict--

Formula: Break-Even ROAS = 1 / Margin. Net Profit = (Revenue x Margin) - Ad Spend. At 50% margin, you need 2.0x ROAS to break even.

Budget Projection Calculator

Model monthly output from daily budget, CPC, and conversion rate.

Daily budgetGBP 100

Avg CPCGBP 1.20

Conversion rate3.5%

Avg order valueGBP 35

Daily clicks--

Daily conversions--

Monthly spend--

Monthly conversions--

Monthly CPA--

Monthly revenue--

Projected ROAS--

Formula: Daily Clicks = Budget / CPC. Daily Conv = Clicks x CVR. Monthly = x 30.4. ROAS = Revenue / Spend.

Germany Scaling Projector

Model the impact of scaling DE -- zero competition window. Uses 20% scaling rule.

DE Ritalin daily budgetGBP 50

DE Konzentration daily budgetGBP 30

DE Ritalin CPA (historical)GBP 14.84

DE Konzentration CPA (est.)GBP 22

Avg order value (DE)GBP 36

DE Ritalin: monthly conversions--

DE Ritalin: monthly revenue--

DE Konzentration: monthly conversions--

DE Konzentration: monthly revenue--

Combined DE new monthly spend--

Combined DE new monthly revenue--

Blended DE ROAS--

DE Ritalin CPA based on lifetime 2,468 conversions at GBP 14.84. Konzentration CPA estimated -- new campaign, no competitors. 20% rule: scale budget by max 20% every 5 days once CPA stabilises.

CPA Sensitivity Analysis

How does CPA change when CPC or CVR shifts? Drag to model market conditions.

Base CPCGBP 1.50

CPC change0%

Base CVR3.5%

CVR change0%

Base CPA--

Adjusted CPC--

Adjusted CVR--

New CPA--

CPA change--

Formula: CPA = CPC / CVR. A 20% CPC increase with flat CVR = 20% CPA increase. A 20% CVR improvement with flat CPC = 17% CPA decrease. QS improvements reduce CPC: each QS point = ~10-15% CPC reduction.

12-Month Revenue Forecast

Month-by-month projected revenue based on implementation timeline. Assumes phased improvements from the priority sequence.

Monthly ad spendGBP 20,000

Post-refresh ROAS target2.5x

Months to reach target ROAS4 months

Year 1 ad spend

Year 1 projected revenue

Year 1 blended ROAS

Assumes: Month 1 at current 1.36x ROAS (fixing conversion tracking). Months 2-3 creative refresh deployed. Linear ROAS ramp to target over specified months. Steady state thereafter. Spend held constant -- no 20% scaling rule applied here for simplicity.

Budget Reallocation Modeller

Drag market allocation to see total revenue impact. Based on current per-market ROAS (conservative) or projected post-refresh ROAS.

UK allocation45%

DE allocation41%

FR allocation12%

US allocation2%

Total monthly budgetGBP 20,000

Total monthly revenue

Blended ROAS

vs. current revenue

UK: spend / revenue--

DE: spend / revenue--

FR: spend / revenue--

US: spend / revenue--

Current ROAS: UK 1.44x, DE 1.36x (blended w/ brand 3.8x), FR 1.49x, US 0.95x. Post-refresh projections: UK 2.2x, DE 2.5x (incl. Ritalin reactivation), FR 2.0x, US 1.2x. Brand search ROAS included in blended figures.

Neurotransmitter Segment Projector — All Markets v3.1b3 NEW

Model revenue from dopamine & GABA keywords across all 4 markets. Validated volumes from DataForSEO April 2026. Two conversion paths: direct purchase from product pages, and TOFU lead magnet funnel (email nurture → delayed purchase).

Segment	UK	US	DE	FR	Global Total
Dopamine vol/mo	65,000	116,000+	60,600	50,700	292,300+
Avg CPC	GBP 0.31	$0.70-5.74	€0.96	€0.24
GABA vol/mo	15,000	30,580+	16,210	15,650	77,440+
Avg CPC	GBP 1.53	$1.53	€1.78	€1.17
Combined	80,000	146,580	76,810	66,350	369,740+/mo
Serotonin	Not yet researched — expected large				Future
Endorphins	Not yet researched — expected large				Future

Dopamine

Daily budget (all markets)GBP 1,000

Blended CPCGBP 0.55

GABA

Daily budget (all markets)GBP 500

Blended CPCGBP 1.50

Path A — Direct Purchase

Direct purchase CVR2.5%

% traffic sent to product pages50%

Path B — TOFU Lead Magnet Funnel

Landing page → email signup

Email nurture → purchase (14-day)3.5%

Lifetime CVR (90-day retargeting)8.0%

Shared

Avg order valueGBP 35

DOPAMINE

Monthly clicks (all markets)--

Path A — direct purchases--

Path B — email signups--

Path B — funnel purchases (14-day)--

Path B — lifetime purchases (90-day)--

GABA

Monthly clicks (all markets)--

Path A — direct purchases--

Path B — email signups--

Path B — funnel purchases (14-day)--

Path B — lifetime purchases (90-day)--

Combined monthly revenue--

Monthly ad spend--

Blended ROAS--

Effective CPA--

Cost per lead (Path B)--

Validated volumes (DataForSEO April 2026): Dopamine: UK 65k (£0.31), US 116k ($0.70), DE 60.6k (€0.96), FR 50.7k (€0.24). GABA: UK 15k (£1.53), US 30.6k ($1.53), DE 16.2k (€1.78), FR 15.7k (€1.17). Combined addressable: 369,740+/mo. Path A = direct to product page, immediate purchase. Path B = lead magnet download → 7-email 14-day nurture → purchase. Path B has lower immediate CVR but builds email list + enables retargeting for 90-day lifetime value. Health supplement email nurture benchmarks: 3-5% 14-day, 8-12% lifetime (90-day). Traffic split slider controls what % goes to each path.

Neurotransmitter Projections Pt 2 — High-Intent Direct Purchase v3.1b3 NEW

MOFU/BOFU keywords only: "dopamine supplements", "gaba supplements", "best dopamine supplement" etc. Purchase-ready searchers sent to fast static HTML/JS landing pages with interactive quiz + product matcher. No ebooks, no email nurture — straight to purchase.

Keyword Cluster	Global vol/mo	Avg CPC	Intent	Landing Page
"dopamine supplements"	~25,000	GBP 0.31-0.70	Purchase-ready	Quiz → product match
"gaba supplement"	~43,000	GBP 1.17-1.78	Purchase-ready	Quiz → product match
"best dopamine supplement"	~5,000	GBP 0.70-2.00	Comparison	Quiz → product match
"best gaba supplement"	~3,500	GBP 1.50-2.00	Comparison	Quiz → product match
Combined high-intent	~76,500/mo

Landing page strategy: Fast static HTML/JS (sub-1s load, no PageFly). Interactive symptom-match quiz: scratch card reveal → 4 visual questions (15-20 seconds) → personalised product recommendation with match % score → one-click purchase. Optionally: 60-90s animated VSL auto-playing muted with captions. Interactive ingredient explorer. Coffee/energy drink cost comparison calculator.

Dopamine (high-intent)

Daily budget (all markets)GBP 1,000

Blended CPCGBP 0.50

GABA (high-intent)

Daily budget (all markets)GBP 1,000

Blended CPCGBP 1.50

Quiz landing page CVR5.0%

Avg order valueGBP 35

Monthly ad spend

Monthly revenue

ROAS

DOPAMINE

Daily clicks--

Daily conversions--

CPA--

Monthly revenue--

ROAS--

GABA

Daily clicks--

Daily conversions--

CPA--

Monthly revenue--

ROAS--

Combined monthly revenue--

Combined CPA--

Combined ROAS--

Annual revenue projection--

Scenario	Daily Budget	Quiz CVR	CPA	Monthly Rev	ROAS	Annual Rev
Conservative	GBP 2,000	5%	GBP 11.00	GBP 96,727	1.59x	GBP 1.16M
Moderate	GBP 2,000	7%	GBP 7.86	GBP 135,418	2.23x	GBP 1.63M
Aggressive	GBP 2,000	10%	GBP 5.50	GBP 193,454	3.18x	GBP 2.32M
Scaled (moderate)	GBP 5,000	7%	GBP 7.86	GBP 338,545	2.23x	GBP 4.06M

Why this works: "Dopamine supplements" / "gaba supplement" searchers are purchase-ready — they've already decided to buy, they just need the right product. Standard Shopify product pages convert at 2-3%. An interactive quiz landing page (scratch card reveal → 4 visual questions → personalised product match → one-click buy) targets 5-10% CVR. Sub-1s page load (static HTML/JS, no PageFly) eliminates the 53% mobile bounce rate from slow pages. At GBP 0.50 blended CPC for dopamine, even 5% CVR gives GBP 10 CPA — half the GBP 20 target. Validate this route first before investing in TOFU ebook infrastructure.

Page Speed CVR Impact v3.1b3 NEW

Replacing PageFly with fast static HTML/JS landing pages. Industry benchmark: 1s faster load = 7% CVR uplift.

Current page load (seconds)5.0s

Target page load (seconds)1.5s

Current monthly revenue (all ads)GBP 32,000

CVR uplift per second saved7%

Seconds saved--

CVR uplift factor--

Additional monthly revenue--

PageFly adds 2-3s of JavaScript overhead. Static HTML/JS pages load in under 1.5s. Google research: 53% of mobile users abandon pages taking over 3s. Deloitte: 0.1s faster = +8% conversions (retail). Conservative 7% per second used here.

New Campaign Portfolio v3.1b4 UPDATED

Combined projected impact of 14 Search + 16 PMax campaigns. v4.0b architecture: 1 campaign per intent cluster per market (was 4 campaigns with 26 asset groups).

Campaign Type	Count	Markets	Daily Budget	Status
Search campaigns (deployed)	6	UK, DE, FR	GBP 110/day	PAUSED
Search campaigns (ready)	1	US	GBP 15/day	READY
Search campaigns (blocked)	7	UK, DE, FR, US	GBP 63/day	BLOCKED (landing pages)
Search total	14		GBP 188/day
PMax campaigns (new intent-split)	12	UK, DE, FR, US	GBP 390/day	PAUSED
PMax campaigns (legacy brand)	4	UK, DE, FR, US	GBP 60/day	ACTIVE
PMax total	16		GBP 450/day

Search campaign blended ROAS2.0x

PMax blended ROAS1.8x

Search daily budget (14 campaigns)GBP 188

PMax daily budget (16 campaigns)GBP 450

Search: monthly spend--

Search: monthly revenue--

PMax: monthly spend--

PMax: monthly revenue--

Combined new monthly revenue--

Blended ROAS--

14 Search campaigns total: 6 deployed (UK Problem-Aware, UK Dopamine & Smart Focus, DE Ritalin ADHS, DE Konzentration, FR Anti-Fatigue Mentale, FR TDAH & Ritaline), 1 ready (US Brain Fog), 7 blocked by landing pages. 16 PMax campaigns: 12 new intent-split (v4.0b architecture) + 4 legacy brand. 13 asset groups fully deployed with assets, listing groups, search themes, and audience signals. Budget: Search GBP 188/day, PMax GBP 450/day. Conservative ROAS: Search 2.0x (new campaigns, learning phase), PMax 1.8x.

Sessions 2 + 3 changes. 15 total changes recorded. 3 ROAS guardrails applied then correctly rolled back.

Changes already made (Session 2 -- 31 Mar & 1 Apr 2026)

1. Paused 7 Demand Gen campaigns (GBP 3,476/mo waste at 0.21x ROAS)

2. Paused CTV Awareness campaign (GBP 416/mo, 0 conversions)

3. Paused YouTube Retarget campaign (GBP 180/mo, 0 conversions)

4. Set PMax UK budget to GBP 300/day

5. Set PMax DE budget to GBP 300/day

6. Set PMax FR budget to GBP 150/day

7. Added 13 ADHD medication negative keywords

8. Created Focus & Attention ad group with 10 problem-aware keywords

9. Set SERP UK ADHD budget to GBP 30/day

10. Paused PMax US Adderall Test (GBP 136/mo saved)

11. Reduced PMax USA budget to GBP 30/day (GBP 1,500/mo saved)

12. Raised SERP DE brand CPC ceiling to GBP 2.00

13. US Brand Search reverted to Target Impression Share (done by user)

14. Enabled PMax DE Ritalin + Austria at GBP 0.01/day (blocked on feed)

15. YouTube follow-on views moved to Secondary

Changes rolled back (Session 3 -- 1 Apr 2026)

R1. Removed Target ROAS 200% from PMax UK → uncapped Max Conv Value

R2. Removed Target ROAS 200% from PMax DE → uncapped Max Conv Value

R3. Removed Target ROAS 200% from PMax FR → uncapped Max Conv Value

Reason for rollback: Creative refresh must happen before bid guardrails. ROAS floors on 24-month-old stale creative suppress delivery and prevent PMax from finding new winning combinations.

Still pending (Manual UI required)

Manual: Audit all 29 conversion actions -- reduce to Purchase-only as Primary

Manual: YouTube follow-on views conversion → disable entirely (currently Secondary, should be removed)

Manual: Remove RecoverUp conversion actions from Brainzyme account

Manual: Fix PMax DE Ritalin feed issue in Merchant Center

Manual: Create 5 new Search campaigns per file 05 specs (API broken -- T5)

Manual: Add RSA ads to SERP UK ADHD Focus & Attention ad group

Manual: Add sitelinks, callouts, structured snippets to ALL Search campaigns

Manual: Add brand exclusions to PMax campaigns

Manual: Verify Consent Mode v2 on brainzyme.de and brainzyme.fr

Manual: Test USA checkout tag with Tag Assistant + VPN

Manual: Remove "Ohne Nebenwirkungen" from DE ad copy, fix FR "Traitement", fix US Elite pricing

Technical issues encountered

ID	Issue	Severity	Workaround
T1	switch_bidding_strategy fails on PMax	Medium	Use generic_mutate with explicit field path
T2	generate_keyword_ideas blocked (Explorer token)	Medium	Use search terms, web research, UI Planner
T5	create_campaign completely broken (5 failure modes)	High	All campaigns via Google Ads UI
T6	Flux Kontext Max rejects 4:5 aspect ratio	Low	Use 3:4 instead

MCP tool reliability (29 tools tested)

Reliable

Partial

Broken

Blocked

Untested

v3.1b4 Deployment Milestone (4 April 2026). v4.0b PMax deployment complete.

12 new PMax campaigns created via create_pmax_campaigns.py (1 per intent cluster per market)
13 asset groups deployed via deploy_pmax.py (full assets, listing groups, search themes, audience signals)
Backfill completed: MC feeds linked, listing groups created, audience signals built via backfill_pmax.py
DE policy exemption: 46/46 ADHS/Ritalin search themes created via exempt_policy_violation_keys
5 bugs fixed in deploy_pmax.py: CustomAudienceService, audience wrappers, proto-plus, FieldMask
New scripts: create_pmax_campaigns.py, backfill_pmax.py
City localisation strategy designed (Edinburgh A/B test planned)
Budget: Search GBP 110/day (6 deployed), PMax GBP 450/day (16 campaigns)

v3.1b4 Appendixes (4 April 2026). Campaign expansion, keyword validation, PMax targeting, top-of-funnel strategy, and neurotransmitter company vision. Each section has feedback controls.

New campaign ready for deployment. "SERP UK Dopamine & Smart Focus new April 2026" — GBP 20/day, 3 ad groups, 38 keywords. Targets trending dopamine demand, smart drugs alternatives, and GABA supplements.

Campaign Settings

Setting	Value
Status	PAUSED (awaiting approval)
Budget	GBP 20/day
Bidding	Maximize Conversions
Geo	United Kingdom (PRESENCE only)
Networks	Search only
Language	English

Ad Groups

Ad Group	Keywords	CPC	Landing Page	Key Angle
Dopamine Supplements	10	GBP 1.50	Focus Pro (GBP 29)	Trending 50% YoY UK. Natural dopamine support.
Smart Drugs Alternative	16	GBP 1.50	Focus Pro (GBP 29)	Legal alternative to modafinil/adderall. Plant-based focus.
GABA Supplements	12	GBP 1.50	Focus Elite (GBP 47)	Precursor formula beats pure GABA (blood-brain barrier). "Like a small glass of wine."

Campaign-Level Negatives

prescriptionmedicationdoctorNHSGPcurediagnosisbuy onlineillegalside effects

Compliance Notes

GABA copy uses "support" language only — never claims to treat anxiety
Smart drugs copy positions as legal plant-based alternative — never promotes illegal drug purchase
Prescription-intent keywords excluded via negatives

All 153 keywords validated via DataForSEO. ~25 queries across 4 markets (UK/DE/FR/US). Original 79 keywords expanded and validated. Net: 15 ad groups, 153 keywords, GBP 115/day.

Key Volume Findings

Keyword	Market	Vol/mo	CPC	Trend
dopamine supplements	UK	2,400	GBP 0.36	+50% YoY
gaba supplement	UK	3,600	GBP 1.74	Stable
brain fog supplements	UK	1,300	GBP 1.87	Stable
nootropika	DE	1,600	EUR 1.67	Stable
complement alimentaire concentration	FR	480	EUR 1.56	Stable
nootropics	US	74,000	USD 3.75	High competition
gaba supplement	US	27,100	USD 1.53	Major opportunity
brain fog	US	60,500	USD 1.45	High volume

Ad Group Verdicts

Ad Group	Market	Verdict	Change
Brain Fog	UK	EXPAND	+Mental Fatigue merged in, 7→13 kw
Cant Concentrate	UK	EXPAND	6→10 kw
Focus & Attention DKI	UK	TRIMMED	5 zero-vol removed, 5→11 kw net
Ritalin Alt	DE	EXPAND	+Adderall/Modafinil merged, 7→11 kw
ADHS Supplement	DE	EXPAND	Umlaut fixes, 7→11 kw
Konzentration	DE	EXPAND	+tabletten, 5→10 kw, budget £15→£20
Fokus	DE	LAUNCH	4→7 kw
Nootropika & Gehirn	DE	EXPAND	Renamed, +nootropika 1,600/mo, 4→8 kw
Anti-Fatigue	FR	REWRITE	10/mo→2,180/mo, complete rewrite
Energie Mentale	FR	CUT	0/mo all keywords — removed
Concentration Travail	FR	REWRITE	90/mo→2,570/mo, rewritten
Ritaline Alt	FR	EXPAND	+Sans Ordonnance merged, 3→6 kw
TDAH Complement	FR	NEW	New ad group, 8 kw, ~380/mo
Dopamine Supplements	UK	NEW	10 kw, 2,400/mo trending
Smart Drugs Alt	UK	NEW	16 kw, ~77K/mo head terms
GABA Supplements	UK	NEW	12 kw, 3,600/mo

All 18 PMax asset groups updated with validated targeting. Search themes at 25/25 cap, custom audience keywords expanded with dopamine/GABA/smart drugs terms, real Google Ads criterion IDs assigned.

Targeting Summary

Signal Type	Count	Source
Search Themes	450 total (25 per group)	DataForSEO validated, max cap reached
Custom Audience Keywords	UK: 170 \| DE: 152 \| FR: 135 \| US: 152	Includes dopamine, GABA, smart drugs, nootropics
In-Market: 80943	All 18 groups	Nutrition Drinks & Shakes
In-Market: 80228	Student groups only	Post-Secondary Education
Affinity: 90400	All 18 groups	Health & Fitness Buffs
Affinity: 90600	All 18 groups	Green Living Enthusiasts

Gap: Google Ads has no supplements/vitamins/cognitive health in-market segment. Custom audiences (keyword-based) are the primary targeting mechanism. In-market/affinity IDs above are the closest available — they serve as secondary signals only.

New Dopamine/GABA Audience Keywords Added

Market	Sample Keywords Added	Total New
UK	dopamine supplements, gaba supplement, smart drugs, modafinil alternative, nootropics uk, brain pills	+24
DE	dopamin, gaba supplement, gehirndoping, modafinil alternative, nootropika, brain booster	+15
FR	dopamine, gaba complement alimentaire, nootropique, smart drugs, booster cerveau	+11
US	dopamine supplements, gaba supplement, nootropics, brain fog supplements, focus supplements	+21

Content-to-Capture-to-Convert. Informational searchers land on lead magnet pages, opt in via email, receive 7-email nurture sequence over 14 days, convert to customers. Avoids head-on bidding wars on expensive transactional keywords.

4 Lead Magnets

#	Guide	Product Link	Target Keywords	Priority
1	"The Dopamine Guide"	Focus Pro	dopamine supplements, how to increase dopamine, dopamine boost	Highest Trending, cheapest CPC
2	"The GABA Guide"	Focus Elite	gaba supplement, how to increase gaba, gaba for anxiety	High Competitive moat
3	"Brain Fog Recovery Plan"	Focus Pro	brain fog, brain fog supplements, brain fog causes	High UK+US demand
4	"Smart Focus Guide"	Focus Pro	smart drugs, study drugs, modafinil alternative	Medium UK-specific

Email Nurture Structure (per guide)

Day	Email Type	Purpose
0	Welcome + download	Deliver guide, set expectations
2	Education	Teach, debunk myths (no pitch)
4	Social proof	Customer story + subtle product mention
7	Science	Ingredient evidence, link to science page
9	Authority	"What 2,000+ doctors recommend"
11	Offer	Product recommendation + 10% discount code
14	Urgency	Final CTA, code expires

3-Phase Rollout

Phase	When	What
1	Immediate	UK Dopamine & Smart Focus campaign with product page landings
2	2-4 weeks	UK lead magnet landing pages built, switch informational keywords to guide pages
3	After UK proven	Replicate to US (largest volume), then DE, then FR

KPI Targets

Cost per Lead

< GBP 3

Lead-to-Customer

> 5%

Effective CPA

< GBP 20

Funnel ROAS

> 350%

Strategic vision: Brainzyme as the specialist brain chemistry company. Not a generic nootropics brand — a neurotransmitter-by-neurotransmitter system. No competitor positions this way.

Product-to-Pathway Mapping

Neurotransmitter	Product	Price	Status	Key Messaging
Dopamine	Focus Pro™	GBP 29	LIVE	Focus, motivation, drive. "Feel the drive."
GABA	Focus Elite™	GBP 47	LIVE	Calm focus, relaxation, social comfort. Precursor formula (BBB differentiator). "Like a small glass of wine."
Serotonin	TBD	TBD	FUTURE	Mood, emotional balance, wellbeing
Endorphins	TBD	TBD	FUTURE	Stress resilience, natural euphoria, pain management

GABA Competitive Moat

Pure GABA supplements cannot cross the blood-brain barrier. Brainzyme Elite uses a precursor mechanism to build the GABA pipeline naturally. This is a genuine scientific differentiator that most GABA supplement brands cannot match. Customer language: "Like having a small glass of wine — relaxed, socially comfortable, less inhibited."

Strategic Implications

Keyword strategy: Each neurotransmitter = its own keyword cluster (dopamine, GABA, serotonin, endorphins)
Ad copy: Each product gets neurotransmitter-specific messaging angles
Lead magnets: One educational guide per neurotransmitter per market
Product line: Serotonin and endorphin products complete the 4-pillar system
Competitive positioning: "The brain chemistry company" vs generic "focus supplement" brands

Keyword Opportunity (validated April 2026)

Neurotransmitter	UK Vol/mo	US Vol/mo	Status
Dopamine	65K	86K	Campaign live
GABA	15K	113K	Campaign live
Serotonin	TBD	TBD	Future
Endorphins	TBD	TBD	Future

Brainzyme Google Ads -- Audit & Strategy Dashboard

Creative Refresh Impact Projector

Impression Share Opportunity

Break-Even ROAS Calculator

Budget Projection Calculator

Germany Scaling Projector

CPA Sensitivity Analysis

12-Month Revenue Forecast

Budget Reallocation Modeller

Neurotransmitter Segment Projector — All Markets v3.1b3 NEW

Neurotransmitter Projections Pt 2 — High-Intent Direct Purchase v3.1b3 NEW

Page Speed CVR Impact v3.1b3 NEW

New Campaign Portfolio v3.1b4 UPDATED